Crossmark

Clinical efficacy of single intraoperative 500 mg methylprednisolone management therapy for thoracic myelopathy caused by ossification of the ligamentum flavum

Crossref DOI link: https://doi.org/10.1186/s12891-020-03216-2

Published Online: 2020-03-19

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huo, Xiaoyang

Zhou, Jiaming

Liu, Shiwei

Guo, Xing

Xue, Yuan
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81871124)
License Information

Text and Data Mining valid from 2020-03-19

Version of Record valid from 2020-03-19
More Information

Article History

Received: 23 December 2019

Accepted: 13 March 2020

First Online: 19 March 2020

Ethics approval and consent to participate

: The Ethical Committee of Tianjin Medical University General Hospital approved the protocol for this investigation and all investigations were conducted in conformity with ethical principles of research. The Ethical NO. is IRB2019-WZ-119.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below